Now US anti-abortion groups block FDA appointment

27 August 2006

The long-winded nomination process for Andrew von Eschenbach to be confirmed as Commissioner on a permanent basis at the US Food and Drug Administration took another twist when anti-abortion groups called on US President George W Bush to withdraw his nomination.

Wendy Wright, president of the Concerned Women of America, a 500,000-member Christian pressure-group, claims that the FDA is ignoring opponents of the application by Barr Laboratories' Plan B (levonorgestrel; Marketletters passim) emergency contraceptive for over-the-counter sales to persons over 18 years. Paul Schenk, director of the National Pro-Life Action Center, an activist who was arrested and convicted of obstruction of justice during a 1992 protest, said: "if the President pushes for this nominee, he is only going to undercut the support of his own party needs in the [November mid-term] elections."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight